© 2 0 1 9 I n d I a n J o u r n a l o f P a t h o l o g y a This study aimed to analyze the frequency of carcinoid tumor, the applied treatments to cure it, and the survival periods of the patients thereafter in a city located in the west of Turkey, Balıkesir. Materials and Methods: The data for this study were gathered by the careful retrospective analysis of 6369 files of patients who underwent an appendectomy operation during the time span of January 2011 and December 2017 in Balıkesir Atatürk City Hospital. Results: The results revealed that among the patients who underwent appendectomy, 17 carcinoid tumor cases, 16 of which with combine classic carcinoid and 1 with goblet cell carcinoid, were recorded. It was discovered that about two times more carcinoid tumors were found in females compared to males. It was also revealed that in the 14 (82.4%) of the patients, the diameter of the tumor was <1 cm. Since the diameter of the tumor is <2 cm in classic carcinoid cases, these patients were only observed. Moreover, within the 5-year follow-up period, no recurrence or progress of carcinoid syndrome was detected. Furthermore, this study found out that the 5-year-survival rate of all the carcinoid tumor patients involved in the study was 100%. Conclusions: It is highly important that the histopathological diagnosis of the patients after appendectomy be carefully followed as the appendicitis carcinoid tumors which are encountered more commonly in women than in men are asymptomatic and can only be incidentally detected.
INTRODUCTION
Malignant appendix tumors, which are among the factors causing acute appendicitis, are seen in 0.9%-1.6% of the samples taken after an appendectomy. [1, 2] Carcinoid tumors are the most common tumors found in the appendix. [3, 4] The combine (classic and tubular) carcinoid tumors make up 50%-70% of the neoplasms detected after appendicitis. [4] The slightly differentiating goblet cell carcinoid (GCC) neoplasms which have neuroendocrine and mucinous are encountered less frequently and have more aggressive progress than combined classic carcinoid (CCC). [4] [5] [6] The appendix carcinoid tumors are not clinically diagnosable. [4] Thus, this study sets out to investigate the incidences of carcinoid tumors, the applied treatment methods, and the survival rate after operation of those undergoing appendectomy operation in the city of Balıkesir where the majority of people have Eagean culinary tradition.
SUBJECTS AND METHODS
The data for this retrospectively carried out study were obtained by the analysis of 6369 files of patients who underwent appendectomy operation during the time span of January 2011 and December 2017 in Balıkesir Atatürk City Hospital located in the west of Turkey. The histopathological reports of patient samples taken after appendectomy in the pathology archive were meticulously evaluated. All the samples taken after surgery included in these reports were fixed in 10% phosphate-buffered formaldehyde and stored in paraffin. Moreover, the sections obtained from the samples were stained with hematoxylin and eosin and then prepared for routine light microscopy. In addition, they were stained with neuron-specific enolase (NSE), chromogranin A, synaptophysin, and Ki-67.
Then, all the samples were evaluated and reported by an expert pathologist. After the histopathological reports of samples taken after appendectomy were prepared, they were uploaded to the information system of the hospital. This enabled the researchers to determine the age, gender, preoperative clinical findings, past operation, histopathological examination results, and 5-year survival rate of patients with neuroendocrine tumors (NETs) from the hospital information system. In the hospital where the study is carried out, newly diagnosed patients have still been followed by annual controls for 5 years. Patients' follow-ups have been realized by the careful examination of ultrasonography, calf catecholamine and metabolites, valine mandelic acid and 5 hydroxyindolacetic acid urine levels, carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 because of being tumor markers in addition to scanning gallium-68 positron emission tomography/computed tomography every 12 months. 
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Statistical analysis
The data obtained from this study were transferred to the SPSS program (Version 16.0; SPSS, Chicago, IL, USA) and then analyzed. The number, percentage, mean, and standard deviation values were utilized for the evaluation of descriptive statistics.
RESULTS
The study revealed that 17 (0.27%) of the 6369 patients who underwent appendectomy had a carcinoid tumor. Also, the development of CCC type carcinoid tumor in 16 (%94.1) and GCC type carcinoid tumor in 1 (%5.9) of these patients was identified. The mean age of the patients was 33.47 (range: 10-77 years), and it was found out that 1.83 times more carcinoid tumors were observed in females than males. Moreover, it was discovered that the GCC type carcinoid tumor afflicted a 62-year-old male patient [ Table 1 ]. Twelve (70.6%) of the patients were also recorded to have mucosal localization, and 14 (82.4%) of the patients were found to develop the carcinoid tumor with <1 cm diameter. However, only one patient was diagnosed to have a carcinoid tumor with >2 cm diameter [ Table 2 ]. Only 15 (88.2%) of the patients underwent appendectomy surgery, whereas 2 (11.8%) patients had right hemicolectomy operation. During the follow-ups of the patients, no recurrence was encountered [ Table 3 ]. Only one patient with CCC and mesoappendix involvement underwent right hemicolectomy operation. While 16 (94.1%) incidences of carcinoid tumors were detected after acute appendicitis, 1 (5.89%) was identified during the total abdominal hysterectomy with bilateral salpingo oophorectomy (TAH + BSO) surgery after the examination of the suspected material. It was discovered that the tumor detected in appendectomy during the TAH + BSO operation, which was performed due to uterine myoma is CCC type, was 0.5 cm in diameter and had a mucosal location. Histopathologically, it was found that the tumor was in stage 1, well-differentiated, and had a Ki-67 index of 1%. All the carcinoid tumors were examined immunohistochemically and stained with NSE, chromogranin, and synaptophysin. Interestingly, all the classic carcinoid cases were observed to be positively stained with chromogranin and synaptophysin. Even though no case of combine classic carcinoid was found to have a lymphovascular or angiolymphatic invasion, only one patient was identified to have developed intra-appendiceal nerves (perineural invasion). This patient with perineural invasion was identified to have a Ki-67 proliferation index of 1% to 2%. As for the GCC case, the tumor cells were characterized by large, eosinophilic, and granular cytoplasm. It was further observed that there were microglandular tiny goblet cell islands in hematoxylin-eosin-stained sections of samples of the patient with GCC tumor. When examined immunohistochemically, this tumor cell was discovered to be diffusely stained with chromogranin but only partially with synaptophysin. One patient with GCC tumor was found to have developed intra-appendiceal nerves and angiolymphatic invasion. The Ki-67 proliferation index of the patient with GCC tumor was found to be 8%. This patient underwent right hemicolectomy operation 1 month after the appendectomy surgery. Because a focal tumor was detected in the material obtained during the secondary right hemicolectomy operation, chemotherapy was used in the treatment of the patient after the operation. Regarding the follow-up of the patients diagnosed with combined classical and GCC, no recurrence of the tumor was observed. Also, no signs of carcinoid syndrome were encountered during the 5-year follow-up period of all the patients. 
DISCUSSION
Carcinoid tumors are those originating from enterochromaffin cells (ECs). As NET cells can secrete bioactive peptides, they can cause the development of such symptoms as flushing and diarrhea in patients. The incidence of NETs ranges from 2.48 to 5.86 per 100,000 people. [7] Forty-eight percent of the malignant tumors caused by NETs are found in the gastrointestinal tract, 25% in the lung, and 9% in the pancreas. Though less frequently, NETs can also develop from many other organs like breast, prostate, thymus, and skin. [8] The NETs produce hormones and similar peptides. These produced biomarkers are used for diagnosis and treatment. Well-differentiated NETs tumors are divided into subgroups according to their histopathological characteristics are EC serotonin producing carcinoid and its tubular variation with L-cell enteroglucagon, and peptide YY producing a tumor. [3] The carcinoid syndrome is developed by the systemic circulation of the hormones secreted by NETs. Carcinoid syndromes develop due to the hormones that cannot be metabolized and are secreted into the system in case of liver metastasis. [7, 9] As a result of the hormones secreted by NETs, it was reported that clinical syndromes of insulinoma were observed in 27.2%, gastrinoma in 12.5%, glucagon in 8%, vipoma in 6.4%, and somatostatinoma in 3.8% of the patients. [10] The incidence of appendicitis carcinoid tumor ranges from 0.2% to 1.6%. [4, 5, 11] As for our study, the incidence of carcinoid tumor was identified to be 0.27% [ Table 1 ]. In the studies conducted by Barreto et al., appendicitis carcinoid incidences were observed to be 1.6% in samples taken from appendectomy operation of 506 patients with acute and chronic. [11] Nevertheless, in studies carried out in our country, the incidence of carcinoid tumors was found to be 0.2% and 0.37%, respectively, in the samples taken after an appendectomy. [4, 12] This low incidence of carcinoid tumor rate is considered to be the result of the differences in genetic and feeding habits of the studied population. As has been previously reported in the literature, carcinoid tumors are encountered twice as common in females as in males. [11, 13] The findings of this study regarding the incidence rate of the carcinoid tumors according to gender are similar to those found in the related literature. According to the World Health Organization (WHO), appendicitis NETs are classified as highly differentiated classical carcinoid tumors (G1), less-differentiated GCC neoplasms (G2) with neuroendocrine and mucinous differentiation, and high-grade neuroendocrine carcinoma (G3). [14] [15] [16] The European Neuroendocrine Tumor Society classification criteria are used to group NETs. The evaluation is conducted by the proliferation index and a number of mitoses. If the Ki-67 index is <2%, (grade 1), between 3% and 20%, moderate (grade 2), and >20%, high-grade "neuroendocrine carcinoma" (grade 3) classifications are made. [17, 18] Appendiceal carcinoid tumors are divided into three subgroups according to their glandular characteristics, that is, classic, tubular, and goblet cell tumor. [19, 20] Carcinoid tumors of the appendix are generally asymptomatic because of their small size and are diagnosed incidentally during the histopathological examination. [21] The CCC type carcinoids make up 50%-70% of neoplasms observed after appendicitis.
They are made up of cells which have typical morphological features and with small, uniform, eosinophilic cytoplasmic, and centered rough chromatin nuclei [ Figure 1 ]. This study revealed that classic carcinoid was encountered in 94.1% of the patients. Diffusion staining with chromogranin-A and synaptophysin was detected in our classical carcinoid cases [ Figures 2 and 3] and Ki-67 proliferation index was <2% [ Figure 4 ]. Different from these classic appearances, other variations have been put forward in the literature. [22] Classical carcinoid tumors tend to grow slowly, and it is quite rare that they develop lymph node metastases. That is why the vast majority of patients with carcinoid tumors have a good prognosis. However, carcinoid tumors of appendix do not usually show any clinical signs and are thus incidentally detected in appendectomy samples. [23, 24] In this study, the diagnosis of carcinoid tumors was made by histopathological examination after the appendectomy and TAH + BSO.
It is necessary that a right hemicolectomy operation be performed in cases where carcinoid tumors are present in the presence of lymph node involvement and the tumor diameter is >2 cm. However, in cases where carcinoid tumors are <1 cm in diameter, only appendectomy is indicated to suffice for treatment. [6, 18, [21] [22] [23] [24] [25] [26] In our research, it was revealed that 82.4% of the carcinoid tumors had a diameter <1 cm [ Table 2 ]. In the literature, complementary right hemicolectomy operation is recommended provided that there is mesoappendix involvement in 1-2 cm tumors or the surgical margin is not clear. However, some surgeons find performing only appendectomy adequate although there is mesoappendix involvement in patients with a tumor of <2 cm diameter. [24] In this study, in the two (11.8%) patients with a tumor diameter of 1-2 cm, the tumor diameter was measured to be 11 mm and perineural invasion was detected and thus, secondary right hemicolectomy was performed.
Classical carcinoid tumors include neuroendocrine differentiation, whereas GCC tumors have both neuroendocrine and glandular differentiation. GCCs originate from pluripotent intestinal stem hemicolectomy is recommended to those patients who have a tumor diameter of 1-2 cm. If there are patients with mesoappendix involvement and GCC tumors >2 cm in diameter, right hemicolectomy, chemotherapy initiation, and strict follow-ups are recommended. [27, 28] In the light of the recommendations in the literature, the patient who complied with the aforementioned criteria in our study had right hemicolectomy, omentectomy, peritonectomy, and lymph node dissection operation 1 month after the appendectomy. Six types of chemotherapy cycles were applied. It is stated in the literature that lymph node involvement and recurrence may occur in tumors which have a diameter >2 cm. [27] The diameter of the GCC tumor was 2.5 cm, and lymph node metastasis was not detected in the complementary right hemicolectomy materials. In our study, no recurrence was observed to develop in any of our patients with carcinoid tumors. In addition, no carcinoid syndrome symptoms and indicators were encountered. In the classic carcinoid tumors of the appendix, it is reported that there is a high expectation of long-term survival for patients. GCC tumors have more intensive progress than classic carcinoid tumors. [27, 28] The 5-year survival rate in patients with CCC tumors is 70%-91%, whereas this is 60%-81% in GCC tumors. [22, 23] As for the patients in our study, 100% of them have completed the 5-year survival span.
CONCLUSIONS
The carcinoid tumor seen in the appendix is usually asymptomatic and it can show symptoms similar to those of appendicitis. However, if the appendix has hard, yellow areas when the material taken during appendectomy is examined macroscopically, then the carcinoid tumor is to be suspected. As carcinoid tumors of appendix are usually detected incidentally, histopathological diagnosis should, therefore, be conducted meticulously.
cells. [17, 22] While patients with a GCC tumor <1 cm in diameter are advised to perform only appendectomy and follow-ups, right 
